OxyDial Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$700K
- Investors
-
3
OxyDial General Information
Description
Developer of oxygen-hemoglobin equilibrium testing instruments intended for research and medical purposes. The company's platform aims to deliver fast, simple, and portable OEC testing, enabling researchers and medical professionals to understand the relationship between blood oxygen and hemoglobin, and diagnose conditions like anemia.
Contact Information
Website
www.oxydial.comCorporate Office
- 50 South 16th Street
- Suite 1800
- Philadelphia, PA 19102
- United States
Corporate Office
- 50 South 16th Street
- Suite 1800
- Philadelphia, PA 19102
- United States
OxyDial Timeline
OxyDial Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Seed Round | 20-May-2026 | $700K | Completed | Generating Revenue | ||
| 3. Accelerator/Incubator | 16-Jun-2025 | Completed | Generating Revenue | |||
| 2. Seed Round | 22-May-2023 | $450K | $450K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | Completed | Generating Revenue |
OxyDial Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-1 | ||||||||
| Seed-4 | ||||||||
| Seed-3 | 595,805 | $0.000100 | 5% | $0.42 | $0.42 | 1x | $0.42 | 4.81% |
| Seed-2 | 357,525 | $0.000100 | 5% | $0.28 | $0.28 | 1x | $0.28 | 2.89% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
OxyDial Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
OxyDial Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
OxyDial Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Science Center | Accelerator/Incubator | |||
| Ben Franklin Technology Partners of Southeastern Pennsylvania | Accelerator/Incubator | |||
| Capital Factory | Accelerator/Incubator | Minority |
OxyDial FAQs
-
When was OxyDial founded?
OxyDial was founded in 2022.
-
Where is OxyDial headquartered?
OxyDial is headquartered in Philadelphia, PA.
-
What is the size of OxyDial?
OxyDial has 15 total employees.
-
What industry is OxyDial in?
OxyDial’s primary industry is Diagnostic Equipment.
-
Is OxyDial a private or public company?
OxyDial is a Private company.
-
What is the current valuation of OxyDial?
The current valuation of OxyDial is .
-
What is OxyDial’s current revenue?
The current revenue for OxyDial is .
-
How much funding has OxyDial raised over time?
OxyDial has raised $1.15M.
-
Who are OxyDial’s investors?
Science Center, Ben Franklin Technology Partners of Southeastern Pennsylvania, and Capital Factory have invested in OxyDial.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
